Viewing Study NCT05288660


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-04-21 @ 12:42 PM
Study NCT ID: NCT05288660
Status: COMPLETED
Last Update Posted: 2023-05-09
First Post: 2022-03-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of a Single Dose of ALXN1210 in Healthy Participants
Sponsor: Alexion Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ALXN1210 View
None Pharmacokinetic View
None Pharmacodynamic View
None Safety View
None Immunogenicity View